Children's Hospital of Philadelphia, Pennsylvania
Nadir Yehya, MD, MSCE is an Associate Professor of Anesthesiology and Critical Care and Pediatrics at the Perelman School of Medicine at the University of Pennsylvania, and an attending physician in the pediatric intensive care unit at CHOP. Dr. Yehya’s research interests encompass all aspects of pediatric critical illness, with a particular emphasis on acute respiratory failure, acute respiratory syndrome (ARDS), and mechanical ventilation. His long-term goal is better characterization of ARDS in children and to test therapies designed to improve outcomes. Dr. Yehya has several active studies involving biomarkers, clinical epidemiology, trial methodology, and pathophysiological mechanisms in the field of pediatric sepsis and ARDS. He is a graduate of the University of California at Los Angeles School of Medicine. After completing pediatrics training at Children’s Hospital of Los Angeles, he completed his pediatric critical care fellowship at Children’s Hospital of Philadelphia (CHOP).
More Cases, Higher Costs, Renewed Risk: National PARDS Trajectory Before and After COVID-19
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
Temporal Shifts in Pediatric ARDS Mortality Disparities Across Racial/Ethnic Groups, 2016-2022
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
Geography Amplifies Racial Inequities in Pediatric ARDS Outcomes Across U.S. Regions
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
Neighborhood Factors and the Association With Ward-to-Pediatric Intensive Care Unit Transfers
Sunday, March 22, 2026
9:45 AM - 10:45 AM Central Time
Disclosure information not submitted.
New Mental Health Diagnoses and Psychotropic Med Starts in Year Following PARDS
Sunday, March 22, 2026
2:30 PM - 3:30 PM Central Time
Disclosure information not submitted.
Hourly Patterns of Caregiver Presence in the PICU: A Descriptive Study
Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Disclosure information not submitted.
Opioid and Illicit Substance Disorders After Pediatric ARDS: Evidence From a U.S. Claims Cohort
Monday, March 23, 2026
10:15 AM - 11:15 AM Central Time
Disclosure information not submitted.
Predictors of Poor Outcomes in Pediatric Sepsis-Induced ARDS: Prospective Cohort Study From an LMIC
Monday, March 23, 2026
11:30 AM - 12:30 PM Central Time
Disclosure information not submitted.
Advances in Biomarkers in Pediatric Acute Respiratory Distress Syndrome
Tuesday, March 24, 2026
8:13 AM - 8:21 AM Central Time
Disclosure(s): No relevant financial relationship(s) to disclose.
Inflammatory Subphenotypes After Cardiopulmonary Bypass in Neonates With Congenital Heart Disease
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.